price
CL
NASDAQ · CLLS
Cellectis S.A.
Healthcare · Biotechnology
$1.26
Up+$0.01 (+0.80%)
Updated Oct 10, 2026, 6:22 AM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 523.7M
- P/E ratio
- -8.66
- Dividend yield
- 0.00%
- 52-week range
- $1.22 – $4.55
- Volume
- 75.76K
- Avg. volume
- 146.61K
Price performance · CLLS
CLLS price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
CLLS closed at $1.26 after 21 trading sessions, down 59.35% for the selected period.
- Last close
- $1.26
- Period change
- -59.35%
- Period low
- $1.25
- Period high
- $3.10
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $1.27 | $1.29 | $1.25 | $1.26 | 75.76K |
| Oct 8, 2026 | $1.28 | $1.3061 | $1.2205 | $1.25 | 106.83K |
| Oct 7, 2026 | $1.35 | $1.40 | $1.33 | $1.34 | 62.46K |
| Oct 6, 2026 | $1.42 | $1.44 | $1.37 | $1.40 | 75.79K |
| Oct 5, 2026 | $1.43 | $1.4369 | $1.38 | $1.41 | 37.27K |
| Oct 2, 2026 | $1.45 | $1.4729 | $1.42 | $1.43 | 47.51K |
| Oct 1, 2026 | $1.47 | $1.50 | $1.40 | $1.40 | 140.74K |
| Sep 30, 2026 | $1.48 | $1.525 | $1.47 | $1.51 | 67.41K |
| Sep 29, 2026 | $1.41 | $1.47 | $1.40 | $1.47 | 32.67K |
| Sep 28, 2026 | $1.4669 | $1.50 | $1.43 | $1.48 | 58.05K |
| Sep 25, 2026 | $1.45 | $1.48 | $1.4149 | $1.47 | 37.74K |
| Sep 24, 2026 | $1.4117 | $1.445 | $1.36 | $1.43 | 68.81K |
| Sep 23, 2026 | $1.50 | $1.59 | $1.41 | $1.44 | 169.81K |
| Sep 22, 2026 | $1.53 | $1.62 | $1.53 | $1.56 | 76.32K |
| Sep 21, 2026 | $1.53 | $1.55 | $1.4648 | $1.51 | 90.04K |
| Sep 18, 2026 | $1.48 | $1.55 | $1.452 | $1.53 | 249.55K |
| Sep 17, 2026 | $1.45 | $1.55 | $1.4301 | $1.46 | 347.33K |
| Sep 16, 2026 | $1.43 | $1.51 | $1.25 | $1.375 | 673.29K |
| Sep 15, 2026 | $1.65 | $1.6877 | $1.55 | $1.61 | 781.23K |
| Sep 14, 2026 | $2.32 | $2.42 | $1.75 | $1.83 | 1.18M |
| Sep 11, 2026 | $3.105 | $3.18 | $3.01 | $3.10 | 75.58K |
Latest CLLS news
The latest Smart Investors Daily articles mentioning CLLS.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…